These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 24262798)

  • 1. Evidence for activation of the unfolded protein response in collagen IV nephropathies.
    Pieri M; Stefanou C; Zaravinos A; Erguler K; Stylianou K; Lapathitis G; Karaiskos C; Savva I; Paraskeva R; Dweep H; Sticht C; Anastasiadou N; Zouvani I; Goumenos D; Felekkis K; Saleem M; Voskarides K; Gretz N; Deltas C
    J Am Soc Nephrol; 2014 Feb; 25(2):260-75. PubMed ID: 24262798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequency of COL4A3/COL4A4 mutations amongst families segregating glomerular microscopic hematuria and evidence for activation of the unfolded protein response. Focal and segmental glomerulosclerosis is a frequent development during ageing.
    Papazachariou L; Demosthenous P; Pieri M; Papagregoriou G; Savva I; Stavrou C; Zavros M; Athanasiou Y; Ioannou K; Patsias C; Panagides A; Potamitis C; Demetriou K; Prikis M; Hadjigavriel M; Kkolou M; Loukaidou P; Pastelli A; Michael A; Lazarou A; Arsali M; Damianou L; Goutziamani I; Soloukides A; Yioukas L; Elia A; Zouvani I; Polycarpou P; Pierides A; Voskarides K; Deltas C
    PLoS One; 2014; 9(12):e115015. PubMed ID: 25514610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autosomal dominant form of type IV collagen nephropathy exists among patients with hereditary nephritis difficult to diagnose clinicopathologically.
    Imafuku A; Nozu K; Sawa N; Hasegawa E; Hiramatsu R; Kawada M; Hoshino J; Tanaka K; Ishii Y; Takaichi K; Fujii T; Ohashi K; Iijima K; Ubara Y
    Nephrology (Carlton); 2018 Oct; 23(10):940-947. PubMed ID: 28704582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upregulated expression of integrin α1 in mesangial cells and integrin α3 and vimentin in podocytes of Col4a3-null (Alport) mice.
    Steenhard BM; Vanacore R; Friedman D; Zelenchuk A; Stroganova L; Isom K; St John PL; Hudson BG; Abrahamson DR
    PLoS One; 2012; 7(12):e50745. PubMed ID: 23236390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemical chaperones to the rescue of Alport syndrome?
    Vanacore RM
    Kidney Int; 2024 Sep; 106(3):359-361. PubMed ID: 39174196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelial cell-specific collagen type IV-α
    Funk SD; Bayer RH; Miner JH
    Am J Physiol Renal Physiol; 2019 May; 316(5):F830-F837. PubMed ID: 30724107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COL4A3/COL4A4 mutations link familial hematuria and focal segmental glomerulosclerosis. glomerular epithelium destruction via basement membrane thinning?
    Voskarides K; Pierides A; Deltas C
    Connect Tissue Res; 2008; 49(3):283-8. PubMed ID: 18661361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel mutation of COL4A3 presents a different contribution to Alport syndrome and thin basement membrane nephropathy.
    Hou P; Chen Y; Ding J; Li G; Zhang H
    Am J Nephrol; 2007; 27(5):538-44. PubMed ID: 17726307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endoplasmic reticulum stress and proteasome pathway involvement in human podocyte injury with a truncated COL4A3 mutation.
    Zhang HD; Huang JN; Liu YZ; Ren H; Xie JY; Chen N
    Chin Med J (Engl); 2019 Aug; 132(15):1823-1832. PubMed ID: 31306228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequent COL4 mutations in familial microhematuria accompanied by later-onset Alport nephropathy due to focal segmental glomerulosclerosis.
    Papazachariou L; Papagregoriou G; Hadjipanagi D; Demosthenous P; Voskarides K; Koutsofti C; Stylianou K; Ioannou P; Xydakis D; Tzanakis I; Papadaki A; Kallivretakis N; Nikolakakis N; Perysinaki G; Gale DP; Diamantopoulos A; Goudas P; Goumenos D; Soloukides A; Boletis I; Melexopoulou C; Georgaki E; Frysira E; Komianou F; Grekas D; Paliouras C; Alivanis P; Vergoulas G; Pierides A; Daphnis E; Deltas C
    Clin Genet; 2017 Nov; 92(5):517-527. PubMed ID: 28632965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A human-mouse chimera of the alpha3alpha4alpha5(IV) collagen protomer rescues the renal phenotype in Col4a3-/- Alport mice.
    Heidet L; Borza DB; Jouin M; Sich M; Mattei MG; Sado Y; Hudson BG; Hastie N; Antignac C; Gubler MC
    Am J Pathol; 2003 Oct; 163(4):1633-44. PubMed ID: 14507670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic renal failure and shortened lifespan in COL4A3+/- mice: an animal model for thin basement membrane nephropathy.
    Beirowski B; Weber M; Gross O
    J Am Soc Nephrol; 2006 Jul; 17(7):1986-94. PubMed ID: 16775036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Collagen type IV-related nephropathies in Portugal: pathogenic COL4A3 and COL4A4 mutations and clinical characterization of 25 families.
    Nabais Sá MJ; Storey H; Flinter F; Nagel M; Sampaio S; Castro R; Araújo JA; Gaspar MA; Soares C; Oliveira A; Henriques AC; da Costa AG; Abreu CP; Ponce P; Alves R; Pinho L; Silva SE; de Moura CP; Mendonça L; Carvalho F; Pestana M; Alves S; Carvalho F; Oliveira JP
    Clin Genet; 2015 Nov; 88(5):456-61. PubMed ID: 25307543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COL4A3 mutations and their clinical consequences in thin basement membrane nephropathy (TBMN).
    Wang YY; Rana K; Tonna S; Lin T; Sin L; Savige J
    Kidney Int; 2004 Mar; 65(3):786-90. PubMed ID: 14871398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of 47 novel mutations in patients with Alport syndrome and thin basement membrane nephropathy.
    Weber S; Strasser K; Rath S; Kittke A; Beicht S; Alberer M; Lange-Sperandio B; Hoyer PF; Benz MR; Ponsel S; Weber LT; Klein HG; Hoefele J
    Pediatr Nephrol; 2016 Jun; 31(6):941-55. PubMed ID: 26809805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alport syndrome and thin glomerular basement membrane nephropathy: a practical approach to diagnosis.
    Haas M
    Arch Pathol Lab Med; 2009 Feb; 133(2):224-32. PubMed ID: 19195966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A mouse Col4a4 mutation causing Alport glomerulosclerosis with abnormal collagen α3α4α5(IV) trimers.
    Korstanje R; Caputo CR; Doty RA; Cook SA; Bronson RT; Davisson MT; Miner JH
    Kidney Int; 2014 Jun; 85(6):1461-8. PubMed ID: 24522496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nine novel COL4A3 and COL4A4 mutations and polymorphisms identified in inherited membrane diseases.
    Rana K; Tonna S; Wang YY; Sin L; Lin T; Shaw E; Mookerjee I; Savige J
    Pediatr Nephrol; 2007 May; 22(5):652-7. PubMed ID: 17216251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tauroursodeoxycholic acid ameliorates renal injury induced by COL4A3 mutation.
    Yu S; Gu X; Zheng Q; Liu Y; Suhas T; Du W; Xie L; Fang Z; Zhao Y; Yang M; Xu J; Wang Y; Lin MH; Pan X; Miner JH; Jin Y; Xie J
    Kidney Int; 2024 Sep; 106(3):433-449. PubMed ID: 38782199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A unique evolution of the kidney phenotype in a patient with autosomal recessive Alport syndrome.
    Vischini G; Kapp ME; Wheeler FC; Hopp L; Fogo AB
    Hum Pathol; 2018 Nov; 81():229-234. PubMed ID: 29530752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.